Moneycontrol
HomeNewsBusinessCMFRI to expand research to tap pharma prospects of marine life
Trending Topics

CMFRI to expand research to tap pharma prospects of marine life

CMFRI Director Dr A Gopalakrishnan said there was a growing demand for new bioactive compounds of marine natural origin in pharmaceutical fields.

January 21, 2018 / 14:36 IST
Story continues below Advertisement
Aurobindo Pharma Ltd.

The Central Marine Fisheries Research Institute (CMFRI) here has decided to expand research network to tap pharmaceutical prospects of marine organisms, its top scientist said today.

CMFRI Director Dr A Gopalakrishnan said there was a growing demand for new bioactive compounds of marine natural origin in pharmaceutical fields.

Story continues below Advertisement

He said the institute has already developed and commercialised various nutraceutical products for various diseases such as diabetes, arthritis, cholesterol and obesity.

"In addition, several products from marine organisms as promising therapeutic agents against diseases such as thyroid are in pipeline to be out licensed soon," Gopalakrishnan said in a release.